Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asahi Kasei Pharma Corp.

Division of Asahi Kasei Corp.
www.asahi-kasei.co.jp/asahi/en/

Latest From Asahi Kasei Pharma Corp.

Venture Funding Deals: Late Summer Sees Slew Of Series B Mega-Rounds

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced in August and September.

Deals Financing

Finance Watch: Landos Raises $60m Series B Round Ahead Of Phase II Data In 2020

If Landos goes public late next year, its financing strategy will align with venture capital and IPO trends observed in a new Jefferies report. Also, D&D Pharmatech raises $137.1m in VC cash, Sonnet secures up to $100m and the CF Foundation commits up to $15m to Arcturus.

Financing Business Strategies

Basilea's Business Strategy Emboldened By $500m Pfizer Deal

Swiss company Basilea has attracted Pfizer as a European partner for its antifungal Cresimba and plans to strengthen its development pipeline with licensed-in products and further collaborations.

Deals Research and Development Strategies

Venture Funding Deals: $65m For Iterum's Antibiotic; Genoa's IPF Drug Nets $62m

Iterum Therapeutics and Genoa Pharmaceuticals topped the list of biopharmaceutical start-up firms closing new venture capital rounds in May with $65m and $62m, respectively, to advance drug candidates for bacterial infections and idiopathic pulmonary fibrosis.

StartUps and SMEs Financing
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Medical Devices
  • Pharmaceuticals
    • Nutraceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Asahi Kasei Corp.
  • Senior Management
  • Toshio Asano, Pres.
  • Contact Info
  • Asahi Kasei Pharma Corp.
    Phone: (81) 03 3507 5777
    1-105 Kanda Jinbocho
    Chiyoda-ku, 101-8101
    Japan
UsernamePublicRestriction

Register